Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,615 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Efficacy and safety of fedratinib in patients with myelofibrosis previously treated with ruxolitinib (FREEDOM2): results from a multicentre, open-label, randomised, controlled, phase 3 trial.
Harrison CN, Mesa R, Talpaz M, Al-Ali HK, Xicoy B, Passamonti F, Palandri F, Benevolo G, Vannucchi AM, Mediavilla C, Iurlo A, Kim I, Rose S, Brown P, Hernandez C, Wang J, Kiladjian JJ. Harrison CN, et al. Among authors: hernandez c. Lancet Haematol. 2024 Oct;11(10):e729-e740. doi: 10.1016/S2352-3026(24)00212-6. Epub 2024 Sep 9. Lancet Haematol. 2024. PMID: 39265613 Clinical Trial.
Safety and efficacy of fedratinib in patients with myelofibrosis previously treated with ruxolitinib: primary analysis of FREEDOM trial.
Gupta V, Yacoub A, Mesa RA, Harrison CN, Vannucchi AM, Kiladjian JJ, Deeg HJ, Fazal S, Foltz L, Mattison RJ, Miller CB, Parameswaran V, Brown P, Hernandez C, Wang J, Talpaz M. Gupta V, et al. Among authors: hernandez c. Leuk Lymphoma. 2024 Sep;65(9):1314-1324. doi: 10.1080/10428194.2024.2346733. Epub 2024 Jun 5. Leuk Lymphoma. 2024. PMID: 38838026 Free article. Clinical Trial.
Efficacy and safety of baricitinib in hospitalized adults with severe or critical COVID-19 (Bari-SolidAct): a randomised, double-blind, placebo-controlled phase 3 trial.
Trøseid M, Arribas JR, Assoumou L, Holten AR, Poissy J, Terzić V, Mazzaferri F, Baño JR, Eustace J, Hites M, Joannidis M, Paiva JA, Reuter J, Püntmann I, Patrick-Brown TDJH, Westerheim E, Nezvalova-Henriksen K, Beniguel L, Dahl TB, Bouscambert M, Halanova M, Péterfi Z, Tsiodras S, Rezek M, Briel M, Ünal S, Schlegel M, Ader F, Lacombe K, Amdal CD, Rodrigues S, Tonby K, Gaudet A, Heggelund L, Mootien J, Johannessen A, Møller JH, Pollan BD, Tveita AA, Kildal AB, Richard JC, Dalgard O, Simensen VC, Baldé A, de Gastines L, Del Álamo M, Aydin B, Lund-Johansen F, Trabaud MA, Diallo A, Halvorsen B, Røttingen JA, Tacconelli E, Yazdanpanah Y, Olsen IC, Costagliola D; EU SolidAct study group. Trøseid M, et al. Crit Care. 2023 Jan 10;27(1):9. doi: 10.1186/s13054-022-04205-8. Crit Care. 2023. PMID: 36627655 Free PMC article. Clinical Trial.
A Pilot Study of the Gut Microbiota in Spine Fusion Surgery Patients.
Cyphert EL, Clare S, Dash A, Nixon JC, Raphael J, Harrison J, Heilbronner A, Kim HJ, Cunningham M, Lebl D, Schwab F, Hernandez CJ, Stein EM. Cyphert EL, et al. Among authors: hernandez cj. HSS J. 2025 Feb;21(1):65-72. doi: 10.1177/15563316231201410. Epub 2023 Sep 26. HSS J. 2025. PMID: 39846059 Free PMC article.
Sex Differences in Long COVID.
Shah DP, Thaweethai T, Karlson EW, Bonilla H, Horne BD, Mullington JM, Wisnivesky JP, Hornig M, Shinnick DJ, Klein JD, Erdmann NB, Brosnahan SB, Lee-Iannotti JK, Metz TD, Maughan C, Ofotokun I, Reeder HT, Stiles LE, Shaukat A, Hess R, Ashktorab H, Bartram L, Bassett IV, Becker JH, Brim H, Charney AW, Chopra T, Clifton RG, Deeks SG, Erlandson KM, Fierer DS, Flaherman VJ, Fonseca V, Gander JC, Hodder SL, Jacoby VL, Kotini-Shah P, Krishnan JA, Kumar A, Levy BD, Lieberman D, Lin JJ, Martin JN, McComsey GA, Moukabary T, Okumura MJ, Peluso MJ, Rosen CJ, Saade G, Shah PK, Sherif ZA, Taylor BS, Tuttle KR, Urdaneta AE, Wallick JA, Wiley Z, Zhang D, Horwitz LI, Foulkes AS, Singer NG; RECOVER Consortium. Shah DP, et al. JAMA Netw Open. 2025 Jan 2;8(1):e2455430. doi: 10.1001/jamanetworkopen.2024.55430. JAMA Netw Open. 2025. PMID: 39841477 Free PMC article.
Prevalence and mortality associated with multidrug-resistant infections in adult intensive care units in Argentina (PREV-AR).
Cornistein W, Balasini C, Nuccetelli Y, Rodriguez VM, Cudmani N, Roca MV, Sadino G, Brizuela M, Fernández A, González S, Águila D, Macchi A, Staneloni MI, Estenssoro E; Prevar Study Group. Cornistein W, et al. Antimicrob Agents Chemother. 2025 Jan 22:e0142624. doi: 10.1128/aac.01426-24. Online ahead of print. Antimicrob Agents Chemother. 2025. PMID: 39840911
Protocol for the enhanced management of multimorbid patients with COPD and severe asthma: role of indoor air quality.
Gómez-López A, Arismendi E, Cano I, Farre R, Figols M, Hernández C, Montilla-Ibarra A, Sánchez-Ruano N, Sánchez B, Sisó-Almirall A, Sorribes M, Vela E, Piera-Jiménez J, Benavent J, Fermoso J, Roca J, González-Colom R. Gómez-López A, et al. Among authors: hernandez c. BMJ Open Respir Res. 2025 Jan 20;12(1):e002589. doi: 10.1136/bmjresp-2024-002589. BMJ Open Respir Res. 2025. PMID: 39837595 Free PMC article.
Effect of Replacing Inorganic Copper, Zinc, and Selenium with Chelated Minerals on Productive Performance, Nutrient Utilization, Tibia Morphology, and Intestinal Histology of Growing Japanese Quail (Coturnix japonica).
Gaona Rodríguez CA, Barragán HB, Vásquez Aguilar NC, Trejo AM, Ramírez MC, Hernández CR, Rodríguez HG, Sáenz EO, Hernández Escareño JJ. Gaona Rodríguez CA, et al. Among authors: hernandez cr. J Poult Sci. 2025 Jan 17;62:2025003. doi: 10.2141/jpsa.2025003. eCollection 2025. J Poult Sci. 2025. PMID: 39830137 Free PMC article.
Head-to-Head Comparison Between Phosphatidylethanol Versus Indirect Alcohol Biomarkers for Diagnosis of MetALD Versus MASLD: A Prospective Study.
Tavaglione F, Amangurbanova M, Yang AH, Tincopa MA, Ajmera V, Richards L, Butcher C, Hernandez C, Madamba E, Singh S, Bettencourt R, Sirlin CB, Loomba R. Tavaglione F, et al. Among authors: hernandez c. Aliment Pharmacol Ther. 2025 Jan 17. doi: 10.1111/apt.18506. Online ahead of print. Aliment Pharmacol Ther. 2025. PMID: 39825487
2,615 results